Axonics Modulation Technologies Inc
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retent… Read more
Axonics Modulation Technologies Inc (AXNX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.001x
Based on the latest financial reports, Axonics Modulation Technologies Inc (AXNX) has a cash flow conversion efficiency ratio of 0.001x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($922.00K) by net assets ($664.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Axonics Modulation Technologies Inc - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how Axonics Modulation Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Axonics Modulation Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Axonics Modulation Technologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SkyWest Inc
NASDAQ:SKYW
|
0.102x |
|
DLVEY
PINK:DLVEY
|
N/A |
|
Reply SpA
PINK:RPYTF
|
0.112x |
|
The Campbell's Company
SA:C1PB34
|
0.057x |
|
COPT Defense Properties
NYSE:CDP
|
0.057x |
|
SHANG.FOS.PHARM.GR.H YC 1
F:08HH
|
N/A |
|
Beijing New Building Materials Public Ltd Co
SHE:000786
|
0.021x |
|
Dairy Farm International Holdings Limited
PINK:DFILF
|
0.850x |
Annual Cash Flow Conversion Efficiency for Axonics Modulation Technologies Inc (2016–2023)
The table below shows the annual cash flow conversion efficiency of Axonics Modulation Technologies Inc from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $637.56 Million | $-2.02 Million | -0.003x | -156.50% |
| 2022-12-31 | $570.14 Million | $3.19 Million | 0.006x | +105.71% |
| 2021-12-31 | $482.44 Million | $-47.31 Million | -0.098x | +66.35% |
| 2020-12-31 | $287.37 Million | $-83.74 Million | -0.291x | +36.10% |
| 2019-12-31 | $183.00 Million | $-83.45 Million | -0.456x | -108.28% |
| 2018-12-31 | $143.28 Million | $-31.37 Million | -0.219x | -142.59% |
| 2017-12-31 | $-35.35 Million | $-18.17 Million | 0.514x | +7.59% |
| 2016-12-31 | $-36.28 Million | $-17.34 Million | 0.478x | -- |